Episode 281: Highlights From Angiogenesis 2021, including discussion of port delivery system, gene therapy for geographic atrophy, home OCT monitoring, and faricimab for AMD

281.jpg

Drs. Carl Regillo, Nadia Waheed, Anat Loewenstein, and Jeffrey Heier join to discuss their respective talks at the Angiogenesis 2021 meeting, including the port delivery system phase 3 results, gene therapy for geographic atrophy, home OCT monitoring with artificial intelligence, and faricimab phase 3 results for AMD.

Relevant Financial Disclosures:
Dr. Regillo is a consultant and receives research grant funding from Genentech. Dr. Loewenstein is a consultant for Notal Vision. Dr. Waheed receives research funding from Gyroscope. Dr. Heier is a consultant and receives research grant funding from Genentech. Dr. Sridhar is a consultant for Regeneron.

You can now claim CME credits via the AAO website. Visit https://www.aao.org/browse-multimedia?filter=Audio&sub=ONE.ContentTypes.Audio.

Jayanth SridharJournal Club, Medical RetinaComment